Ambrx Biopharma Inc. Increase (Decrease) in Accounts Receivable
Ambrx Biopharma Inc. reported Increase (Decrease) in Accounts Receivable of -$295.00 thousand for the 6-month period ending 2023-06-30, per its 10-Q filed 2023-08-09.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2023-08-09
- Ambrx Biopharma Inc. increase (decrease) in accounts receivable for the quarter ending 2023-06-30 was $19.00K.
- Ambrx Biopharma Inc. increase (decrease) in accounts receivable for the quarter ending 2023-03-31 was -$314.00K, a 232.49% decline year-over-year.
- Ambrx Biopharma Inc. increase (decrease) in accounts receivable for the quarter ending 2022-06-30 was -$10.00K.
- Ambrx Biopharma Inc. increase (decrease) in accounts receivable for the quarter ending 2022-03-31 was $237.00K.
- Ambrx Biopharma Inc. increase (decrease) in accounts receivable for fiscal 2022 was -$863.00K, a 206.41% decline from fiscal 2021.
- Ambrx Biopharma Inc. increase (decrease) in accounts receivable for fiscal 2021 was $811.00K.
| Period end | Increase (Decrease) in Accounts Receivable 3 month | Increase (Decrease) in Accounts Receivable 6 month | Increase (Decrease) in Accounts Receivable 12 month |
|---|---|---|---|
| 2023-06-30 | $19.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | -$295.00K 10-Q · filed 2023-08-09 | |
| 2023-03-31 | -$314.00K 10-Q · filed 2023-05-11 | ||
| 2022-12-31 | -$863.00K 10-K · filed 2023-03-30 | ||
| 2022-06-30 | -$10.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $227.00K 10-Q · filed 2023-08-09 | |
| 2022-03-31 | $237.00K 10-Q · filed 2023-05-11 | ||
| 2021-12-31 | $811.00K 10-K · filed 2023-03-30 | ||
| 2021-06-30 | $318.00K 6-K · filed 2022-08-29 | ||
| 2020-12-31 | -$415.00K 20-F · filed 2022-04-26 | ||
| 2019-12-31 | $762.00K 20-F · filed 2022-04-26 |